Ariane Brusselmans

Ariane Brusselmans

Director Programs and Education, ISN

The Royal Liverpool University has been working together with the Al Shifa hospital in Gaza since 2013. Read ‘The Guardian’ report of Salim, a member of the Liverpool team during their last visit to Gaza in February:



Thursday, 28 January 2016 13:09


AKI in Benin

ehfehFEfhFHEifhe

This webinar will identify social, economic and ethnic characteristics of Latin America, recognize the burden of disease risk factors and ESRD in this region and highlight the present gap between estimated incidence of ESRD and real access to therapy.

.  

This presentation was given by Vishal Vaidya, Associate Professor of Medicine and Head of Systems Toxicology for the Harvard Program in Theurapeutic Sciences. It was presented during the CRRT Conference 2015: “Updates in ICU Medicine: Controversies, Challenges and Solutions,” held in San Diego from 17-20 February 2015.

In an educational program a complete and up-to-date Curriculum is essential. The Residents, Fellows, and Practicing Nephrologists rely on their mentors to train them in procedures necessary to provide successful dialysis access. However, since there are several ways to accomplish any goal, the trainees also need a Curriculum which summarizes literature to provide evidence regarding advantages and disadvantages of each technique. This Core Curriculum provides this summary for peritoneal dialysis catheter procedures, which are the sine qua non of a successful dialysis program.

The Curriculum represents a collaborative effort from Interventional Nephrologists in a wide variety of practices, from Universities to Private Hospitals to Access Centers. Each author is a recognized expert in the particular procedure or technique that they present.

vicenza course

 

30th International Vicenza Course on Peritoneal Dialysis

Opening Ceremony

  • Vicenzanephrocourses: Thirty years in three minutes – C. Ronco
  • Lazaro Gotloib Memorial Lecture: Past, present and future of PD – N. Lameire

Session 1: Summit on PD around the world

  • The International Society of Nephrology – G.Remuzzi
  • The European Renal Association ERA-EDTA – R. Vanholder
  • The EUROPD- A. Joerres
  • The International Society of Peritoneal Dialysis – I. Teitelbaum
  • The ISPD – Asian Chapter – K.S. Nayak
  • The American Society of Nephrology – J. Burkart
  • The Chinese Society of Nephrology – Z.H. Liu
  • The European Society of Pediatric Nephrology – E. Verrina
  • The Latin American Society of Nephrology – R. Correa-Rotter
  • The Italian Society of Nephrology – G. Capasso

Session 2: Research in Peritoneal Dialysis – the last and next thirty years

  • Peritoneal Membrane Morphology – G. Garosi
  • Peritoneal transport – B. Rippe
  • Peritoneal Membrane biology – O. Devuyst
  • Peritoneal Dialysis solutions – A. Joerres
  • Treatment modalities and targets – J. Burkart
  • PD in pts with abdominal and thoracic abnomalities – M. Misra

Session 3: Peritoneal Dialysis Solutions

  • Biocompatibility of PD solutions – R. Mehrotra
  • PD solutions and nutritional status – C.Verger
  • 20 years of bicarbonate solutions – M. Feriani
  • Alternative dialysis strategies with icodextrin – I. Teitelbaum
  • Are current solutions adequate for pediatric use? – E. Verrina

Session 4: New challenges for PD and home therapies

Session 4b: Practical Issues in Peritoneal Dialysis

 

  • The financial benefits of home therapies – R. Greenwood
  • When and how to start peritoneal dialysis – M. Schreiber
  • The Brazilian PD Study (BRAZPD) – J. Divino
  • Outcomes: PD vs HD – R. Mehrotra
  • Hypogonadism, wasting and ESA resistance – P. Stenvinkel

 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 

  • Getting the right patient on the right treatment – M. Perez Fontan
  • Barriers and opportunities of home therapies – N. Lameire
  • How to avoid technique failure in PD – J.P. Ryckelynck
  • Ultrafiltration failure: diagnosis & management – W. Van Biesen

Session 5: Telemedicine and e-Health on PD

  • Computer assisted Data Collection and management – C. Ronco
  • Telemedicine in peritoneal dialysis – M. Rosner
  • e-Health: remote health care models in PD – W. Van Biesen
  • Cardiovascular complications in PD patients – D.G Struijk
  • Remote monitoring of PD in special locations – K.S. Nayak

Session 6: Lipid disorders, inflammation and anemia

  • Dialysis option for the very elderly – M. Rosner
  • Anemia management in PD patients – F. Locatelli
  • Maximising EPO response: Iron strategies – K.S. Nayak
  • Lipid disorders in uremia & dialysis – G. Bakris
  • Statins and lipid lowering strategies in PD – O. Heimb├╝rger 

Session 7: CKD-MBD and Inflammation Management in PD

  • Which phosphate binder in PD patients – M. Cozzolino
  • Use of VDR Activitations in PD – J. Bover
  • Calcimimetrics in PD patients – P. Messa
  • Factors affecting loss of residual functions in Dialysis – N. Levin
  • New therapeutic options for inflammation in PD – D. Warrock

Session 8: Fluid overload and cardiovascular

 

 

Session 8b: Practical Issues in Peritoneal Dialysis 2

  • Fluid homeostasis in PD – J. Teixodo
  • BIVA + BNP in PD patients – C. Crepaldi
  • PD in heart failure patients – M. Schreiber
  • Role of PD in Cardio-Renal patients – A. Rodrigues

 
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

  • PD access: what’s the best approach? – M. Riella
  • Catheter placement techniques – W. Van Biesen
  • Infectious complications: treatment considerations – A Joerres
  • Adequacy in peritoneal dialysis – J.P. Ryckelynck
  • Setting up research in PD – J. Witowski

Session 9: Controversies

  • Do we need PD guidelines? Yes, They are useful – N. Lameire
  • Do we need PD guidelines? No, they are dangerous – R. Amerling
  • Take patients off PD after 7 years to prevent EPS? Yes, we must! – F. Finkelstein
  • Take patients off PD after 7 years to prevent EPS? No, there is no need – E. Brown

Session 10: Peritoneal Dialysis Technology

  • Wearable technology: where are we? – C. Ronco
  • Continuous Flow PD – R. Amerling
  • 1 day HD and 5 days PD: does it make sense?  – J. Burkart
  • Time between catheter insertion and use – I. Teitelbaum
  • PD membrane evaluation in clinical practice – R. Krediet

Session 11: Peritonitis and other clinical outcomes

  • Today’s approaches to prevent peritonitis – B. Piraino
  • Transplant outcome and dialysis modality- I. Teitelbaum
  • Pancreas/Kidney transplant in PD patients – M. Schreiber
  • Early diagnosis of Peritonitis: the case of NGAL – F.K. Martino
  • Prognostic factors for peritonitis outcome – D.G. Struijk
  • How to improve the care of diabetic patient on PD – M. Misra
  • How to select among dialysis option – A. Mooney

Session 11: Peritonitis and other clinical outcomes

Session 10: Peritoneal Dialysis Technology

Page 1 of 5

Scroll to Top